•  Continued growth in an uncertain environment

    المصدر: Nasdaq GlobeNewswire / 20 يوليو 2022 10:47:44   America/Chicago

     Continued growth in an uncertain environment

    First half revenue: 1,121.7 million
    Total growth: 12.9%
    Organic growth: 6.9%
    Record first half operating profit: 11.3%

    Paris, July 20, 2022 – Ipsos’ business continues to grow well, despite the effects of the war in Ukraine and new lockdowns in China. The majority of our service lines are seeing double digit growth. We have been able to respond rapidly to rising inflation, which has allowed us to protect our margins.

    Ipsos posted revenue in the first half of the year of €1,121.7 million, up 12.9%, of which 6.9% is organic growth, and 5.4% of exchange rate effects due to the depreciation of the euro and 0.7% of scope effects. Underlying organic growth was 10.6%, after adjusting for the temporary effect of Covid testing contracts with some Western governments during the pandemic, and net of the research projects that could not be completed because of sanitary measures and have been resumed.

    In the second quarter, total growth was 8.9%, of which 2.1% organic growth. Excluding the Covid effect, organic growth in the second quarter was at 7.7%. This reflects the strength of Ipsos’ model in a context made difficult by the war in Ukraine, the new lockdowns in China, as well as the excellent performance recorded in the second quarter of 2021, which led to an unfavorable base effect.

    PERFORMANCE BY QUARTER

      H1 2022 vs. H1 2021
    In millions of
    Euros
    Revenue
    2022
    Total
    growth
    Organic
    growth
    1st quarter 547.8 17.5% 12.3% (1)
    2nd quarter 574.0 8.9% 2.1% *
    Total for the half year 1,121.7 12.9% 6.9% *

    * Underlying cumulative organic growth is 7.7% in the second quarter and 10.6% in the first half of 2022, excluding the temporary net positive impact of Covid-related contracts (specific pandemic monitoring projects for governments, minus contracts that could not be executed because of the health situation).
    (1) Covid-related contracts were maintained at least in part until March 31, 2022

    PERFORMANCE BY REGION

    In millions of Euros H1 2022 Contribution Total growth
    H1 2022/H1 2021
    Organic growth
    H1 2022/H1 2021
    EMEA 498.4 44% 1.4% -1%
    Americas 429.9 38% 27.3% 16%
    Asia-Pacific 193.4 17% 18.0% 10%
    Revenue 1,121.7 100% 12.9% 6.9%

    The Americas were Ipsos’ best performer in the first half of the year, with organic growth of 16%, driven by our large TMT (Technology, Media and Telecommunications) clients and our proprietary platform Ipsos.Digital. The American market, which weighs significantly in this area, is one of the priorities of our 2025 strategic plan "The Heart of Science and Data", and where we are increasing our market share.

    Despite headwinds caused by Covid lockdowns in China, the rest of Asia-Pacific has been bouncing back strongly after the pandemic with total organic growth in the region at 10%.

    The EMEA region was unsurprisingly the most affected by the war in Ukraine. It was also penalized by the end of Covid-related contracts and organic growth was -1%. Excluding temporary Covid-related contracts: organic growth remains solid in the region, at around 6%, particularly in our major markets like the UK, France and Italy.

    PERFORMANCE BY AUDIENCE

    In millions of Euros H1 2021 Contribution Organic growth
    H1 2022/ H1 2021
    Consumers1 522.1 46% 14%
    Customers and employees2 222.1 20% 9%
    Citizens3 187.3 17% -12%
    Doctors and patients4 190.1 17% 8%
    Revenue 1,121.7 100% 6.9%

    Breakdown of Service Lines by audience segment:
    1- Brand Health Tracking, Creative Excellence, Innovation, Ipsos UU, Ipsos MMA, Market Strategy & Understanding, Observer (excl. public sector), Social Intelligence Analytics, Strategy3
    2- Automotive & Mobility Development, Audience Measurement, Customer Experience, Channel Performance (including Retail Performance and Mystery Shopping), Media development, Capabilities
    3- Public Affairs, Corporate Reputation
    4- Pharma (quantitative and qualitative)

    Despite inflationary pressures and disruptions in our customers' supply chains, our core work among consumers grew organically by 14% in the first half. This reflects our clients’ need to understand changing consumer behavior in a post-Covid and inflationary world. As we have said before, uncertainty drives demand for accurate information.

    As societies learn to live with Covid-19, our health business with doctors and patients grew by 8% organically.

    The re-opening of economies, re-opening of hospitality and resumption of travel saw our customer and employee facing businesses grow by 9% organically in the first half.

    After massive growth in the last two years, our citizen-facing businesses are down 12% organically because of the end of covid testing contracts. However, excluding the Covid effect, our activities with governments and the public sector is up 23% organically.

    FINANCIAL PERFORMANCE

    Summary income statement

    In millions of Euros June 30, 2022 June 30, 2021 Change Reminder
    Dec 31, 2021
    Revenue 1,121.7 993.3 12.9% 2,146.7
    Gross margin 739.7 642.8 15.1% 1,389.3
    Gross margin / Revenue 65.9% 64.7%   64.7%
    Operating margin 126.8 109.0 16.3% 277.4
    Operating margin / Revenue 11.3% 11.0%   12.9%
    Other non-operating / non-recurring income and expenses 0.9 0.7   (5.5)
    Finance costs (6.2) (7.0) -11.6% (13.8)
    Income tax (29.5) (23.2)   (62.9)
    Net profit attributable to the owner of the parent 85.5 72.0   183.9
    Adjusted net profit attributable to the owner of the parent* 97.5 81.4   209.2

    *Adjusted net profit is calculated before (i) non-cash items covered by IFRS 2 (share-based payments), (ii) amortization of intangible assets identified on acquisitions (client relationships), (iii) the net tax effect of other non-operating income and expenses, (iv) the non-cash effect on changes in puts in other financial income and expenses and (v) deferred tax liabilities from goodwill, which in some countries can be amortized.

    The gross margin (which is calculated by deducting external and variable costs associated with contract performance from revenue is up 120 basis points to 65.9% compared with 64.7% in the first half of 2021. This increase in the gross margin ratio is linked to the change in the mix of data collection methods and is explained by (i) the termination during the first half of 2022 of the major pandemic monitoring contracts (whose collection costs are higher than average) and (ii) the increase in the proportion of online surveys in the most “digitized” countries, partially balanced by the resumption of offline data collection in the rest of the world after the pandemic. Overall, the proportion of online surveys increased from 60% in the first quarter of 2021 to 62% for the whole year, then to 63% in the first half of 2022. The rise in the gross margin in the first half of 2022 is also the result of our ability to maintain our prices.

    With regard to operating costs, the payroll remains contained in a context of (i) a resumption of recruitment to cope with the growth in activity (these were significantly slowed down during the pandemic and at the beginning of 2021) and (ii) higher inflation. It increased by 14.3%, which is less than the increase in gross margin (15.1%). Payroll, including provision for bonuses, accounts for 68.0% of the gross margin against 72.7% for the same period in 2019. As of June 30, 2022, the permanent workforce was 19,503 employees. The average permanent workforce is up 11,7% between both halves.

    The cost of variable compensation in shares increased to €6.9 million from €5.9 million in 2021.

    Overhead costs increased by nearly €18 million, an increase of 21.6% compared to the first half of 2021 due to (i) the recovery in travel over the past few months - travel expenses, however, remain 45% below the level of the first half of 2019 and (ii) a catch-up of IT current expenses which had been severely constrained during the pandemic. Overall and despite these catch-up effects, overhead costs remain contained in relation to the pre-crisis level and represented 13.9% of gross profit compared with 18.8% in the first half of 2019.

    The item "Other operating income and expenses", which consists mainly of severance costs, shows a negative balance of 1.7 million and is down by almost €3 million compared to the first half of 2021.

    Overall, the Group's operating profit is at 11.3% in the first half of 2022, up 30 basis points compared to the same period last year, establishing a record performance for the first half. Given the cyclical nature of Ipsos’ business, revenue growth and the operating margin are more significant in the second half of the year. The excellent performance of the first half is nonetheless promising for Ipsos to achieve its objectives for the whole of 2022.

    Below the operating margin, the amortization of intangible assets related to acquisitions concerns notably the portion of goodwill allocated to customer relations during the 12 months following the date of acquisition and subject to amortization in the income statement under IFRS over several years. This allocation amounts to €4 million compared to €2.5 million previously. This increase is mainly due to the acquisitions of Karian & Box and Infotools.

    The balance of the item other non-current and non-recurring income and expenses amounted to €0.9 million compared to a balance of €0.7 million last year. This item mainly records income related to the decision to capitalize internal development costs since January 2018. This effect will end at the end of 2022.

    Finance costs. The net interest expense amounted to €6.2 million compared to €7 million the previous year due to (i) a decrease in financial debt in relation to good cash generation and (ii) a renewal and extension of the maturity of a "Shuldschein" loan in euros and dollars for an amount reduced to €78 million with a maturity of 5 to 7 years.

    The effective tax rate on the IFRS income statement was 25.3% compared to 25.2% last year. It includes a deferred tax liability of €2.2 million, which cancels out the tax savings achieved through the tax deductibility of goodwill amortization in certain countries, even though this deferred tax expense would only be due in the event of the disposal of the activities concerned (and is therefore restated in adjusted net profit).

    Net profit attributable to the owner of the parent was €85 million compared to €72 million in the first half of 2021, up 18.8%.

    Adjusted net profit attributable to the owner of the parent, which is the relevant and constant indicator used to measure performance, is also up to €98 million compared to €81 million last year at the same period, up 19.8%.

    Financial structure

    Cash flow. Cash flow from operations amounted to €172 million, compared with €150 million in the first half of 2021.

    The working capital requirement experienced a negative change of €22 million in the first half, due, on the one hand to the increase in activity, and on the other hand to larger bonus payments this half, following an excellent performance in 2021.

    Investments in property, plant and equipment and intangible assets consisted mainly of IT infrastructure investments and amounted to €27 million in the first half of the year, an increase of €8 million compared to the first half of 2021, showing that we have already started the implementation of our 2025 strategic plan, which calls for a significative increase in investments in our platforms, notably Ipsos.Digital, Askia and Infotools.

    Overall, free cash flow from operations, at €53 million, was in line with the forecast for the year, down €40 million compared to the same period last year, due to the increase in activity, the payment of bonuses for 2021 and the increase in investments in technology and platforms, as explained above.

    As regards non-current investments, Ipsos invested approximately €2.3 million in the form of an earn-out payment relating to the acquisition of Infotools and for the acquisition of WeCheck, a small size company specialized in Mystery Shopping in Canada. As for the previous years, a large part of free cash flow will be generated in the second half of 2022.

    Shareholders' equity stood at €1,440 million at June 30, 2022 compared to €1,342 million at December 31, 2021.

    Net financial debt amounted to €154 million, down compared to December 31, 2021 (€180 million) and to June 30, 2021 (€272 million). The net debt ratio fell to 10.7% compared with 13.4% at December 31, 2021 and 22.7% at June 30, 2021. The leverage ratio (calculated excluding the IFRS16 impact) was 0.4 times EBITDA (compared to 0.5 times at December 31, 2021).

    Cash position. Cash at June 30, 2022 amounted to €338 million compared to €298 million at December 31, 2021 and €301 million at June 30, 2021

    The Group also has more than €250 million in credit lines available for more than one year, enabling it to meet its €107 million debt repayments in 2022 and 2023.

    OUTLOOK

    Beyond the very good results of this first half, our order book at the end of June remains solid, recording 14% growth, of which 8% organically.

    We are therefore confident in our ability to achieve organic growth of more than 5% this year and to reach a level of operating margin comparable to that of last year, reaching 12.9%.

    However, the only certainty is uncertainty: central banks are raising interest rates and seeking a soft landing after a period of inflation in most Western countries, while wages remain below inflation almost everywhere, penalising consumers.
    Globally, a second Cold War has effectively begun, while the pandemic continues to disrupt the world, particularly in China, where the government has opted for a zero Covid strategy, which has had major social and economic impacts.

    Despite all these headwinds, we can see that our strategy of the best people combined with the best technology – or as we call it being at “The Heart of Science and Data” - gives us room to continue our growth with our clients, following the lines of the strategic plan we presented at our 2022 Investor Day in June.

    Our market is near $90 billion and Ipsos has a small fraction of it. No competitor now offers the range and diversity of services, or the sectoral cover we now have, giving us room to flex and adapt to new needs of thousands of our clients for reliable information, and to take advantage of opportunities quickly. Our digitisation and automation strategy continues and helps improve our margins.

    * * *
    Presentation of the half-year results 2022:
    Thursday July 21 at 8.30 a.m. at the Hôtel Le Bristol. A conference call in English will take place at 4 p.m. For invitation requests, please contact IpsosCommunications@Ipsos.com.
    The event will be broadcast on our website in English and French.

    ABOUT IPSOS

    Ipsos is one of the largest market research companies in the world, present in 90 markets and employing more than 18,000 people.

    Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques.

    Our tagline "Game Changers" sums up our ambition to help our 5,000 customers move confidently through a rapidly changing world.

    Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120 and Mid-60 indices and is eligible for the Deferred Settlement Service (SRD). ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP
    www.ipsos.com

    Appendices

    Consolidated income statement, Half-yearly financial statements at June 30, 2022

    In thousands of euros 06/30/2022 06/30/2021 12/31/2021
    Revenue 1,121,724 993,317 2,146,725
    Direct costs (382,060) (350,502) (757,391)
    Gross margin 739,664 642,815 1,389,334
    Employee benefit expenses – excluding share-based payments (503,320) (440,460) (896,461)
    Employee benefit expenses - share-based payments* (6,874) (5,885) (12,071)
    General operating expenses (100,963) (83,034) (183,043)
    Other operating income and expenses (1,747) (4,447) (20,381)
    Operating margin 126,759 108,988 277,378
    Amortization of intangible assets identified on acquisitions* (4,018) (2,531) (5,274)
    Other non-operating income and expenses* 856 671 (5,486)
    Share of profit/(loss) of associates 99 (327) 1,671
    Operating profit 123,697 106,801 268,289
    Finance costs (6,195) (7,008) (13,837)
    Other financial income and expenses * (959) (3,724) (4,413)
    Net profit before tax 116,542 96,069 250,038
    Income tax – excluding deferred tax on goodwill amortization (27,265) (21,531) (58,303)
    Deferred tax on goodwill amortization* (2,197) (1,641) (4,608)
    Income tax (29,462) (23,172) (62,911)
    Net profit 87,080 72,897 187,127
    Attributable to the owners of the parent 85,489 71,987 183,923
    Attributable to non-controlling interests 1,590 910 3,204
    Basic net profit per share attributable to the owners of the parent (in euros) 1.93 1.63 4.14
    Diluted net profit per share attributable to the owners of the parent (in euros) 1.88 1.59 4.04


    Adjusted earnings* 99,077 82,143 212,205
    Attributable to the owners of the parent 97,518 81,404 209,223
    Attributable to non-controlling interests 1,558 740 2,982
    Adjusted basic earnings per share, attributable to the owners of the parent 2.20 1.84 4.71
    Adjusted diluted earnings per share, attributable to the owners of the parent 2.15 1.80 4.59

    * Adjusted for non-cash items related to IFRS 2 (share-based compensation), amortization of intangible assets identified on acquisitions (client relationships), deferred tax liabilities related to goodwill for which amortization is deductible in some countries, the impact net of tax of other non-operating income and expenses and the non-cash impact of changes in puts in other financial income and expenses.

    Statement of financial position, Half-yearly financial statements at June 30, 2022

    In thousands of euros 06/30/2022 06/30/2021 12/31/2021
    ASSETS      
    Goodwill 1,420,712 1,296,426 1,360,464
    Right-of-use assets 134,702 121,191 122,935
    Other intangible assets 113,145 96,119 98,899
    Property, plant and equipment 34,211 28,282 31,340
    Investments in associates 7,732 2,686 8,919
    Other non-current financial assets 54,857 54,023 51,961
    Deferred tax assets 24,100 15,678 25,223
    Non-current assets 1,789,460 1,614,404 1,699,741
    Trade receivables 402,949 358,673 555,496
    Contract assets 195,388 184,041 107,114
    Current tax 36,618 39,842 14,045
    Other current assets 66,736 73,928 62,720
    Financial derivatives - (1,287) -
    Cash and cash equivalents 338,289 301,041 298,454
    Current assets 1,039,980 956,238 1,037,830
    TOTAL ASSETS 2,829,440 2,570,642 2,737,571
           
    In thousands of euros 30/06/2022 30/06/2021 31/12/2021
    EQUITY AND LIABILITIES      
    Share capital 11,109 11,109 11,109
    Share paid-in capital 507,588 514,068 508,259
    Treasury shares (794) (445) (643)
    Translation adjustments (43,895) (149,133) (115,406)
    Other reserves 862,517 728,997 746,221
    Net profit, attributable to the owners of the parent 85,393 71,987 183,926
    Equity, attributable to the owners of the parent 1,421,918 1,176,583 1,333,466
    Non-controlling interests 18,515 19,246 8,963
    Equity 1,440,433 1,195,829 1,342,429
    Borrowings and other non-current financial liabilities 454,784 396,093 448,561
    Non-current liabilities on leases 112,472 101,056 102,421
    Non-current provisions 8,430 2,143 7,025
    Provisions for post-employment benefit obligations 34,394 33,631 36,255
    Deferred tax liabilities 94,858 78,272 66,458
    Other non-current liabilities 45,318 26,318 45,549
    Non-current liabilities 750,256 637,515 706,270
    Trade payables 295,921 272,542 332,239
    Borrowings and other current financial liabilities 37,051 175,407 30,349
    Current liabilities on leases 36,098 36,360 34,923
    Current tax 7,626 4,470 25,463
    Current provisions 10,049 7,651 9,967
    Contract liabilities 45,817 40,049 64,329
    Other current liabilities 206,188 200,819 191,603
    Current liabilities 638,751 737,298 688,873
    TOTAL LIABILITIES 2,829,440 2,570,642 2,737,571

    Consolidated cash flow statement, Half-yearly financial statements at June 30, 2022

    In thousands of euros 06/30/2022 06/30/2021 12/31/2021
    OPERATING ACTIVITIES      
    NET PROFIT 87,080 72,897 187,127
    Items with no impact on cash flow from operations      
    Amortization and depreciation of property, plant and equipment and intangible assets 43,121 38,286 79,839
    Net profit of equity-accounted companies, net of dividends received (99) 327 (1,671)
    Losses/(gains) on asset disposals 45 (26) (164)
    Net change in provisions (1,796) 1,641 17,985
    Share-based payment expense 6,018 5,351 11,153
    Other non-cash income/(expenses) (687) (655) (2,459)
    Acquisition costs of consolidated companies 227 323 882
    Finance costs 8,178 8,816 17,349
    Tax expense 29,462 23,172 62,911
    CASH FLOW FROM OPERATIONS BEFORE TAX AND FINANCE COSTS 171,549 150,132 372,952
    Change in working capital requirement (22,419) 32,058 33,538
    Income tax paid (44,961) (45,174) (60,519)
    NET CASH FROM OPERATING ACTIVITIES 104,168 137,017 345,972
    INVESTING ACTIVITIES      
    Acquisitions of property, plant and equipment and intangible assets (27,420) (19,112) (43,512)
    Proceeds from disposals of property, plant and equipment and intangible assets 35 49 128
    (Increase)/decrease in financial assets (1,658) (1,270) (2,003)
    Acquisitions of consolidated activities and companies, net of acquired cash (2,271) (8,792) (29,079)
    CASH FLOW FROM INVESTING ACTIVITIES (31,314) (29,124) (74,466)
    FINANCING ACTIVITIES      
    Share capital increases/(reductions) - - -
    Net (purchases)/sales of treasury shares (16,847) (689) (8,694)
    Increase in long-term borrowings 4 - 75,570
    Decrease in long-term borrowings (41) (102) (167,480)
    Decrease in long-term loans from associates - - 5,704
    Increase/(decrease) in bank overdrafts 302 366 (1,033)
    Net repayment of lease liabilities (18,649) (19,808) (40,308)
    Net interest paid (1,199) (1,973) (13,012)
    Net interest paid on lease liabilities (1,958) (1,865) (3,599)
    Acquisitions of non-controlling interests (723) (956) (956)
    Dividends paid to the owners of the parent - - (39,820)
    Dividends paid to non-controlling interests of consolidated companies - - (1,984)
    Dividends received from non-consolidated companies - - 52
    NET CASH FROM FINANCING ACTIVITIES (39,113) (25,028) (195,561)
    NET CHANGE IN CASH AND CASH EQUIVALENTS 33,742 82,864 75,945
    Impact of foreign exchange rate movements 6,098 2,215 6,559
    CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD 298,454 215,951 215,951
    CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD 338,289 301,041 298,454

     

    Attachment


شارك على،